India gave emergency approval to the world’s second covid-19 vaccine that can be delivered as nasal drops. The vaccine was jointly developed by Covaxin-maker Bharat Biotech and Washington University St.
Louis. Drugs Controller General of India (DCGI) V.G. Somani approved restricted emergency use of the vaccine iNCOVACC (BBV154) for primary two-dose schedule for people above 18 years of age India's COVID-19 tally had crossed the 20-lakh mark on August 7, 2020, 30 lakh on August 23, 40 lakh on September 5 and 50 lakh on September 16.
It went past 60 lakh on September 28, 70 lakh on October 11, crossed 80 lakh on October 29, 90 lakh on November 20 and surpassed the one-crore mark on December 19.